KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Operating Margin: 2010-2024

Historic Operating Margin for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to -270.30%.

  • TherapeuticsMD's Operating Margin rose 9736.00% to -109.95% in Q3 2025 from the same period last year, while for Sep 2025 it was -61.80%, marking a year-over-year increase of 35649.00%. This contributed to the annual value of -270.30% for FY2024, which is 38431.00% up from last year.
  • According to the latest figures from FY2024, TherapeuticsMD's Operating Margin is -270.30%, which was up 58.71% from -654.61% recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Operating Margin registered a high of 1.70% during FY2022, and its lowest value of -3,092.77% during FY2021.
  • Over the past 3 years, TherapeuticsMD's median Operating Margin value was -270.30% (recorded in 2024), while the average stood at -307.74%.
  • In the last 5 years, TherapeuticsMD's Operating Margin plummeted by 285,301bps in 2021 and then spiked by 309,447bps in 2022.
  • Yearly analysis of 5 years shows TherapeuticsMD's Operating Margin stood at -239.77% in 2020, then plummeted by 285,301bps to -3,092.77% in 2021, then surged by 309,447bps to 1.70% in 2022, then tumbled by 65,631bps to -654.61% in 2023, then soared by 38,431bps to -270.30% in 2024.